CytoDyn Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q2 2012 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
CytoDyn Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q2 2012 to Q2 2024.
- CytoDyn Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending May 31, 2024 was $101M, a 4.73% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)